“Around 5 years ago Lyin' Les Goldman used disgraced blogger Chris LaCoursiere to pump an imminent contract with BP which would include an upfront payment and contingent milestone payments. The internet army (see main culprits above) ran with it for weeks. Finally, the news was released in which Merck had agreed to supply Keytruda free of charge for an upcoming combo trial. No cash and no contingent payments (of course the internet army proclaimed this as great news because Merck was just waiting to buy NWBO, why would they throw money at a takeover).”
- I wouldn’t be surprised if we see a similar contract. No upfront payment, just free drug from big pharma in the combo trial. Otherwise no reason to pump this in advance in the 10Q. Besides big pharma wouldn’t allow this as it could potentially open them up for insider trading charges, risk disruption from a competitor, etc.
A quick question for you - how did NWBO fund this trial? And which combo trial was this? I am not aware of any combo trial where NWBO is involved in terms of sponsor.
Market Data 
Markets 
AI
